PARAMUS, N.J., May 1, 2012 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI), announces the addition of Dr. David L. Blecker MD, MPH, F.A.C.P. to the Advisory Board. Dr. Blecker, a graduate of Tufts University School of Medicine, has been practicing medicine for over 39 years and is currently the Chief in Nephrology at AtlantiCare Regional Medical Center. Dr. Blecker is also the Founder of Regional Nephrology Associates, a private practice located in south New Jersey. In addition, Dr. Blecker is an owner and operator of five Dialysis units as well as partner in Regional Nephrology Associates. He has performed clinical trials for various pharmaceutical companies including Amgen Inc., Pfizer and Merck.
"As an expert in preventive medicine and an advocate for clinical trials, I believe that the proprietary technology of Surgex allows athletes, as well as our soldiers, to function at a high performance level without the loss of muscle mass." Dr. Blecker further stated, "A technology that limits muscle waste can be utilized within the medical sector with a focus on degenerative diseases such as cancer and kidney disease."
Dr. Blecker stated, "As an advisory board member of Inergetics, I plan on developing a product and marketing strategy to reduce protein deficiency that exists within dialysis patients."
CEO Mark Mirken commented, "Dr. Blecker's access and experience with dialysis patients is extensive and will allow him to conduct clinical trials within his numerous dialysis units. This product is based on our existing long term care and immune compromised technology and will be accretive to our product portfolio targeting nutritional supplements for the medical marketplace."
About Inergetics, Inc.
Inergetics, Inc. is a leading developer of nutritional supplements for the Clinical Health and Sports Supplement markets
|SOURCE Inergetics, Inc.|
Copyright©2010 PR Newswire.
All rights reserved